National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 27350

History of Changes from the VAERS Wayback Machine

Already in VAERS on 12/31/2003

VAERS ID: 27350
VAERS Form:
Age:50.9
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEPTAVAX / MSD - / - - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: DYSPNEA, ERYTHEMA MULT, ASTHMA, ASTHENIA, ANGIOEDEMA

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type':

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 12/8/2009

VAERS ID: 27350 Before After
VAERS Form:
Age:50.9
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-10 1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEPTAVAX HEP B (HEPTAVAX) / MSD MERCK & CO. INC. - / - - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria, DYSPNEA, ERYTHEMA MULT, ASTHMA, ASTHENIA, ANGIOEDEMA

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': (blank) WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 8/31/2010

VAERS ID: 27350 Before After
VAERS Form:
Age:50.9
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (HEPTAVAX) HEP B (FOREIGN) / MERCK & CO. INC. - / - - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 2/14/2017

VAERS ID: 27350 Before After
VAERS Form:
Age:50.9 50.0
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / - - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 5/14/2017

VAERS ID: 27350 Before After
VAERS Form:
Age:50.0
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / - - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 9/14/2017

VAERS ID: 27350 Before After
VAERS Form:(blank) 1
Age:50.0
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / - UNK - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 2/14/2018

VAERS ID: 27350 Before After
VAERS Form:1
Age:50.0
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / UNK - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 6/14/2018

VAERS ID: 27350 Before After
VAERS Form:1
Age:50.0
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / UNK - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 8/14/2018

VAERS ID: 27350 Before After
VAERS Form:1
Age:50.0
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / UNK - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 9/14/2018

VAERS ID: 27350 Before After
VAERS Form:1
Age:50.0
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / UNK - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.


Changed on 10/14/2018

VAERS ID: 27350 Before After
VAERS Form:1
Age:50.0
Sex:Female
Location:Florida
Vaccinated:1990-04-16
Onset:0000-00-00
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (FOREIGN) / MERCK & CO. INC. - / UNK - / -

Administered by: Unknown      Purchased by: Unknown
Symptoms: Angioneurotic oedema, Asthenia, Asthma, Dyspnoea, Erythema multiforme, Lung disorder, Rash maculo-papular, Urticaria

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Pulmonary function 1990 Bronchospasm; Lung biopsy - 1990- interstitial lung disease.
CDC 'Split Type': WAES90120585

Write-up: Pt vaccinated with Heptavax-B developed angioneurotic edema, urticaria, pruritus, bronchospasm, episodes of flushing, arthralgia, erythematous macular rash thought to be erythema multiforme. Seen in ER given cortisone. Wheezing persisted.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=27350&WAYBACKHISTORY=ON


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166